Elan Lutinger has extensive experience in the pharmaceutical industry, with a focus on clinical development and strategic management. Starting in 2011, Elan held pharmaceutical intern positions at CVS Pharmacy and The Brooklyn Hospital Center, where they gained experience in medication management and patient care.
In 2014, Elan joined Daiichi Sankyo, Inc. as a Post-Doctoral Fellow. They contributed to various aspects of clinical development, including protocol development and management, market research, and data management. They also worked in external scientific affairs, providing market analyses and participating in M&A meetings.
Elan moved on to Novartis in 2016, taking on the role of Senior Global Trial Manager in Immuno-Oncology. They played a key role in managing global clinical trials and providing support for the Disease Area Strategy for CAR-T therapies. They also drafted consulting agreements and collaborated with internal and external stakeholders.
In 2019, Elan joined Johnson & Johnson as a Specialist in CAR-T Immuno-Oncology. They were responsible for advancing clinical development and execution of CAR-T studies, providing expert analysis for key business, regulatory, and clinical questions.
In 2020, Elan joined Valuate Health Consultancy as a Senior Analyst, where they worked on data analysis and provided strategic recommendations.
In 2022, Elan joined Chameleon Communications International as the Vice President of Medical & Scientific Services, where they contribute to the company's medical and scientific initiatives.
Overall, Elan Lutinger brings a wealth of experience in clinical development, strategic management, and pharmaceutical consulting to their current role.
Elan Lutinger obtained a Doctor of Pharmacy (Pharm.D.) degree in Pharmaceutical Sciences from Long Island University from 2008 to 2014. Following this, from 2014 to 2016, Elan pursued a Master of Business Administration (M.B.A.) degree in Executive Management at St. John's University, The Peter J. Tobin College of Business.
Additionally, Elan Lutinger holds several certifications. In April 2019, Elan obtained a Pharmacist certification from the New Jersey Board of Pharmacy. In August 2017, Elan obtained a Pharmacist certification from the New York State Board of Pharmacy. Other certifications obtained by Elan include Pain Management Certification from the New York State Council of Health-system Pharmacists in December 2014, a Certified Clinical Research Coordinator certification from Medidata Solutions in September 2014, and a Biomedical Research & CITI Good Clinical Practice Course certification from the Collaborative Institutional Training Initiative Program at the University of Miami in September 2012.
March, 2022 - present